Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in France

Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in France

Patients with cancer have an increased risk of developing venous thromboembolism (VTE) and an increased risk of death from VTE. Until recently, the standard of care for treatment of VTE in cancer patients was low molecular weight heparins (LMWH). To determine treatment patterns and outcomes, we perf...

Full description

Bibliographic Details
Main Authors: Laurent Bertoletti, Gaelle Gusto, Nadia Quignot, Artak Khachatryan, Jose Chaves, Audrey Moniot, Ruth Mokgokong, Isabelle Mahé
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Cancers
Subjects:
venous thromboembolism
cancer
anticoagulants
bleeding
low molecular weight heparin
medical database
Online Access:https://www.mdpi.com/2072-6694/15/11/3011

Internet

https://www.mdpi.com/2072-6694/15/11/3011

Similar Items